Sign in

CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company

Indaptus Therapeutics, Inc.

Sign in to watch
Ticker
INDP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863158720
Phone
(646) 427-2727
Business address
3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
Former names
Intec Parent Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. SC 13D/A Stake Beneficial Ownership Report
  5. SC 13D/A Stake Beneficial Ownership Report
  6. SC 13D/A Stake Beneficial Ownership Report
  7. RW Other RW
  8. EFFECT Other Notice of Effectiveness
  9. 424B3 Offering Prospectus
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. S-1 Offering Registration Statement
  13. 4 Open-market buy CEO and Director bought 12,000 shares at $7.00 ($84,000)
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. SC 13D Stake Beneficial Ownership Report
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. S-3 Offering Registration Statement
  19. 10-Q Report Quarterly Report
  20. 8-K Event Exhibits

Page 15 of 18 · 343 filings